[1]
Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352(16), 1685-1695.
[2]
Weber, C.; Noels, H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat. Med., 2011, 17(11), 1410-1422.
[3]
Atanasov, A.G.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Linder, T.; Wawrosch, C.; Uhrin, P.; Temml, V.; Wang, L.; Schwaiger, S.; Heiss, E.H.; Rollinger, J.M.; Schuster, D.; Breuss, J.M.; Bochkov, V.; Mihovilovic, M.D.; Kopp, B.; Bauer, R.; Dirsch, V.M.; Stuppner, H. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv., 2015, 33(8), 1582-1614.
[4]
Hageman, J.; Herrema, H.; Groen, A.K.; Kuipers, F. A role of the bile salt receptor FXR in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2010, 30(8), 1519-1528.
[5]
Porez, G.; Prawitt, J.; Gross, B.; Staels, B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J. Lipid Res., 2012, 53(9), 1723-1737.
[6]
Karunakaran, D.; Rayner, K.J. Macrophage miRNAs in atherosclerosis. Biochim. Biophys. Acta, 2016, 1861(12 Pt B), 2087-2093.
[7]
Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1), 15-20.
[8]
Cianciolo, G.; La Manna, G.; Cappuccilli, M.L.; Lanci, N.; Della Bella, E.; Cuna, V.; Dormi, A.; Todeschini, P.; Donati, G.; Alviano, F.; Costa, R.; Bagnara, G.P.; Stefoni, S. VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif., 2011, 32(3), 161-173.
[9]
Nibbelink, K.A.; Tishkoff, D.X.; Hershey, S.D.; Rahman, A.; Simpson, R.U. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 533-537.
[10]
Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 2007, 49(5), 1063-1069.
[11]
Al-Khatib, S.M.; Stevenson, W.G.; Ackerman, M.J.; Bryant, W.J.; Callans, D.J.; Curtis, A.B.; Deal, B.J.; Dickfeld, T.; Field, M.E.; Fonarow, G.C.; Gillis, A.M.; Granger, C.B.; Hammill, S.C.; Hlatky, M.A.; Joglar, J.A.; Kay, G.N.; Matlock, D.D.; Myerburg, R.J.; Page, R.L. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary. Circulation, 2018, 138(13), e210-e271.
[12]
Zhou, C.; Liu, L.; Zhuang, J.; Wei, J.; Zhang, T.; Gao, C.; Liu, C.; Li, H.; Si, H.; Sun, C. A systems biology-based approach to uncovering molecular mechanisms underlying effects of traditional chinese medicine qingdai in chronic myelogenous leukemia, involving integration of network pharmacology and molecular docking technology. Med. Sci. Monit., 2018, 24, 4305-4316.
Related Journals
Protein & Peptide Letters
Related Books
Frontiers in Protein and Peptide Sciences
Article Metrics
25
5
1